Gilead Sciences Q1 earnings beat expectations, but full-year EPS guidance was significantly lowered due to multiple acquisition deals.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, May 8th | Gilead Sciences announced that its first-quarter revenue increased by 4% year-on-year to $6.96 billion, exceeding the market expectation of $6.91 billion; adjusted earnings per share were $2.03, also surpassing the market expectation of $1.91. During the period, sales of the HIV treatment drug Biktarvy grew by 7% to $3.36 billion, slightly higher than the market forecast of $3.32 billion; sales of the oncology drug Trodelvy increased by 37% to $402 million. Looking ahead for the full year, Gilead Sciences raised its revenue guidance to between $30 billion and $30.4 billion. Due to acquisitions including cell therapy company Arcellx, autoimmune drug developer Ouro Medicines, and oncology drug developer Tubulis, the company now expects adjusted loss per share to be between $1.05 and $0.65, compared to the previous forecast of earnings per share between $8.45 and $8.85.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Bitcoin Rally Meets Trump Factor: What Indian Crypto Investors Should Watch
CoinEdition•2026/08/22 08:00

Estoril Sol SGPS holds annual shareholder meeting with 58% of capital represented
Reuters•2026/08/22 07:50
Kona BidCo lifts Zalaris stake to 87.35% voting rights after market buy
Reuters•2026/08/22 07:40
Bitcoin and Gold Are Surging Together: The ‘Debasement Trade’ Is Back
Cryptopotato•2026/08/22 07:12
Crypto prices
MoreBitcoin
BTC
$77,301.8
+1.07%
Ethereum
ETH
$2,431.52
+2.28%
Tether USDt
USDT
$0.9999
+0.04%
XRP
XRP
$1.54
+16.35%
USDC
USDC
$1
+0.01%
Solana
SOL
$94.37
+4.22%
TRON
TRX
$0.3452
+1.86%
Hyperliquid
HYPE
$78.78
+7.05%
Dogecoin
DOGE
$0.09285
+10.83%
Zcash
ZEC
$813.76
+28.01%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now